Periodontal Therapeutics Market Size

Periodontal Therapeutics Market Size

Periodontal Therapeutics Market size was valued at around USD 849.2 million in 2023 and is estimated to grow at 7.7% CAGR from 2024 to 2032. Periodontal therapeutics refers to the medical and dental treatments used to manage and treat periodontal diseases, which are infections and inflammations of the structures around the teeth, including the gums, periodontal ligament, and alveolar bone. The goal of periodontal therapeutics is to halt the progression of periodontal disease, promote healing, and maintain the health of the periodontium.

The increasing prevalence of periodontal diseases, such as gingivitis and periodontitis, are linked to rising rates of diabetes, cardiovascular diseases, and aging populations globally. Innovations in treatment modalities, including advanced local delivery systems for antibiotics like minocycline hydrochloride and doxycycline hyclate, are enhancing the efficacy and patient compliance of periodontal therapies.
 

Additionally, growing awareness and emphasis on oral hygiene and dental preventative supplies contribute to the rising demand for periodontal treatments. The integration of new technologies, such as antimicrobial photodynamic therapy and laser therapy devices, further propels market growth by offering less invasive and more effective options. Moreover, increasing investment in research and development by pharmaceutical companies to develop novel therapeutics and improve existing treatments is expected to sustain market expansion.